Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
sales of 49.16 billion Swiss Francs [US$50.26 billion]
of which 66%
was Innovative Medicines),
(36.20 billion Euro [US$41.76 billion]
of which 83%
was Pharmaceuticals), and
based in Germany
(35.02 billion Euro [US$40.39 billion]
of which 48%
was Pharmaceuticals & Biological Products).
Roche Holding Aktiengesellschaft reported sales of 53.30 billion Swiss Francs (US$54.50 billion)
December of 2017.
increase of 5.4%
versus 2016, when the company's sales were 50.58 billion Swiss Francs.
Sales at Roche Holding Aktiengesellschaft have increased during each of the previous five years
(and since 2012, sales have increased a total of 17%).
Sales of Pharmaceuticals saw an increase
5.4% in 2017, from
39.10 billion Swiss Francs to 41.22 billion Swiss Francs.